Browse our extensive catalog of high-quality chemicals for research and development.
| Product Name | Description | CAS Number | Molecular Formula | Molecular Weight | Description |
|---|---|---|---|---|---|
| Talarozole | N-[4-[2-Ethyl-1-(1H-1,2,4-triazol-1-yl)butyl]phenyl]-2-benzothiazolamine; R 115866; Rambazole; | 201410-53-9 | C21H23N5S | 377.51 | N-[4-[2-Ethyl-1-(1H-1,2,4-triazol-1-yl)butyl]phenyl]-2-benzothiazolamine; R 115866; Rambazole;
|
| 8-Br-PET-cGMP Sodium Salt | 2-Bromo-3,4-dihydro-6-phenyl-3-(3,5-O-phosphinico-beta-D-ribofuranosyl)-9H-imidazo[1,2-a]purin-9-one Sodium Salt; | 185246-29-1 | C18H14BrN5NaO7P | 546.2 | 2-Bromo-3,4-dihydro-6-phenyl-3-(3,5-O-phosphinico-beta-D-ribofuranosyl)-9H-imidazo[1,2-a]purin-9-one Sodium Salt;
|
| Talaporfin-13C4-15N | N-[2-[(7S,8S)-3-Carboxy-7-(2-carboxyethyl)-13-ethenyl-18-ethyl-7,8-dihydro-2,8,12,17-tetramethyl-21H,23H-porphin-5-yl]acetyl]-L-aspartic acid-13C4-15N;N-[[(7S,8S)-3-Carboxy-7-(2-carboxyethyl)-13-ethenyl-18-ethyl-7,8-dihydro-2,8,12,17-tetramethyl-21H,23H-porphin-5-yl]acetyl]-L-aspartic acid-13C4-15N; ME 2906-13C4-15N; Mono-L-aspartyl chlorin e6-13C4-15N; N-Aspartyl chlorin e6-13C4-15N; NPe 6-13C4-15N; | 110230-98-3 Unlabelled | C34 13C4H41N4 15NO9 | 716.72 | N-[2-[(7S,8S)-3-Carboxy-7-(2-carboxyethyl)-13-ethenyl-18-ethyl-7,8-dihydro-2,8,12,17-tetramethyl-21H,23H-porphin-5-yl]acetyl]-L-aspartic acid-13C4-15N... |
| (S)-(-)-Verapamil Hydrochloride | (αS)-α-[3-[[2-(3,4-Dimethoxyphenyl)ethyl]methylamino]propyl]-3,4-dimethoxy-α-(1-methylethyl)-benzeneacetonitrile Hydrochloride; (S)-Verapamil Hydrochloride; (-)-Verapamil Hydrochloride; | 36622-28-3 | C27H39ClN2O4 | 491.06 | (αS)-α-[3-[[2-(3,4-Dimethoxyphenyl)ethyl]methylamino]propyl]-3,4-dimethoxy-α-(1-methylethyl)-benzeneacetonitrile Hydrochloride; (S)-Verapamil Hydro... |
| Talc | 14807-96-6 | H2O3Si 34 Mg | 0 | ||
| Guanosine-3-monophosphate Disodium Salt (mixture of 2&3 isomers) | Disodium 3-GMP; 3-Guanylic Acid Disodium Salt; | 6027-83-4 | C10H12N5Na2O8P | 407.18 | Disodium 3-GMP; 3-Guanylic Acid Disodium Salt;
|
| (R)-(+)-Verapamil-d6 Hydrochloride | (alphaR)-alpha-[3-[[2-(3,4-Dimethoxyphenyl)ethyl]methylamino]propyl]-3,4-dimethoxy-alpha-(1-methylethyl)benzeneacetonitrile-d6 Hydrochloride; (R)-Verapamil-d6 Hydrochloride; Dexverapamil-d6 Hydrochloride; LU 33925-d6; NSC 632821-d6; | 1795786-09-2 | C27H33D6ClN2O4 | 497.1 | (alphaR)-alpha-[3-[[2-(3,4-Dimethoxyphenyl)ethyl]methylamino]propyl]-3,4-dimethoxy-alpha-(1-methylethyl)benzeneacetonitrile-d6 Hydrochloride; (R)-Vera... |
| S-(s)-Verapamil-D6 | (alphaS)-alpha-[3-[[2-(3,4-Dimethoxyphenyl)ethyl]methylamino]propyl]-3,4-dimethoxy-alpha-(1-methylethyl-d6)-benzeneacetonitrile Hydrochloride; (S)-Verapamil-d6 Hydrochloride; (-)-Verapamil-d6 Hydrochloride; | 1329611-24-6 | C27H33D6ClN2O4 | 497.1 | (alphaS)-alpha-[3-[[2-(3,4-Dimethoxyphenyl)ethyl]methylamino]propyl]-3,4-dimethoxy-alpha-(1-methylethyl-d6)-benzeneacetonitrile Hydrochloride; (S)-Ver... |
| Guanosine 5-O-(2-Thiodiphosphate) Trilithium Salt | 97952-36-8 | C10H12Li3N5O10P2S | 477.07 | ||
| Guanosine 3,5-Cyclic Monophosphate | Guanosine 3,5-Phosphate (cyclic); 4H-Furo[3,2-d]-1,3,2-dioxaphosphorin Guanosine Deriv.; 3,5-Cyclic GMP; 3,5-GMP; Cyclic 3,5-GMP; Cyclic 3,5-Guanylic Acid; Cyclic GMP; Cyclic Guanosine 3,5-Monophosphate; Cyclic Guanosine Monophosphate; Guanosine 3,5-Monophosphate; Guanosine 3,5-Phosphate; Guanosine Cyclic 3,5-Monophosphate; Guanosine Cyclic 3,5-Phosphate; cGMP; Guanosine Cyclic 3,5-(Hydrogen Phosphate); | 7665-99-8 | C10H12N5O7P | 345.21 | Guanosine 3,5-Phosphate (cyclic); 4H-Furo[3,2-d]-1,3,2-dioxaphosphorin Guanosine Deriv.; 3,5-Cyclic GMP; 3,5-GMP; Cyclic 3,5-GMP; Cyclic 3,5-Guanylic ... |
Page 5290 of 10017